Interestingly, HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients (Guo et al., 2017; Tejido et al., 2021), suggesting a functional connection between class II HDAC inhibition and FUS, which is in line with our data. The gene discussed is HDAC9; the disease is amyotrophic lateral sclerosis.